BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35145272)

  • 1. Aberrant somatic hypermutation of CCND1 generates non-coding drivers of mantle cell lymphomagenesis.
    Müller H; Walter W; Hutter S; Nadarajah N; Meggendorfer M; Kern W; Haferlach T; Haferlach C
    Cancer Gene Ther; 2022 May; 29(5):484-493. PubMed ID: 35145272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCND1 mutations increase protein stability and promote ibrutinib resistance in mantle cell lymphoma.
    Mohanty A; Sandoval N; Das M; Pillai R; Chen L; Chen RW; Amin HM; Wang M; Marcucci G; Weisenburger DD; Rosen ST; Pham LV; Ngo VN
    Oncotarget; 2016 Nov; 7(45):73558-73572. PubMed ID: 27713153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes.
    Nadeu F; Martin-Garcia D; Clot G; Díaz-Navarro A; Duran-Ferrer M; Navarro A; Vilarrasa-Blasi R; Kulis M; Royo R; Gutiérrez-Abril J; Valdés-Mas R; López C; Chapaprieta V; Puiggros M; Castellano G; Costa D; Aymerich M; Jares P; Espinet B; Muntañola A; Ribera-Cortada I; Siebert R; Colomer D; Torrents D; Gine E; López-Guillermo A; Küppers R; Martin-Subero JI; Puente XS; Beà S; Campo E
    Blood; 2020 Sep; 136(12):1419-1432. PubMed ID: 32584970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-specific transcript variants of cyclin D1 in mantle cell lymphoma and multiple myeloma with chromosome 11q13 abnormalities.
    Chinen Y; Tsukamoto T; Maegawa-Matsui S; Matsumura-Kimoto Y; Takimoto-Shimomura T; Tanba K; Mizuno Y; Fujibayashi Y; Kuwahara-Ota S; Shimura Y; Kobayashi T; Horiike S; Taniwaki M; Kuroda J
    Exp Hematol; 2020 Apr; 84():45-53.e1. PubMed ID: 32145384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mantle cell lymphoma with a novel t(11;12)(q13;p11.2): a proposed alternative mechanism of CCND1 up-regulation.
    Menke JR; Vasmatzis G; Murphy S; Yang L; Menke DM; Tun HW; King RL; Smoley SA; Ketterling RP; Sukov WR
    Hum Pathol; 2017 Jun; 64():207-212. PubMed ID: 28132860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Pathogenesis of Mantle Cell Lymphoma.
    Navarro A; Beà S; Jares P; Campo E
    Hematol Oncol Clin North Am; 2020 Oct; 34(5):795-807. PubMed ID: 32861278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequestration of p27Kip1 protein by cyclin D1 in typical and blastic variants of mantle cell lymphoma (MCL): implications for pathogenesis.
    Quintanilla-Martinez L; Davies-Hill T; Fend F; Calzada-Wack J; Sorbara L; Campo E; Jaffe ES; Raffeld M
    Blood; 2003 Apr; 101(8):3181-7. PubMed ID: 12515730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A defect of the INK4-Cdk4 checkpoint and Myc collaborate in blastoid mantle cell lymphoma-like lymphoma formation in mice.
    Vincent-Fabert C; Fiancette R; Rouaud P; Baudet C; Truffinet V; Magnone V; Guillaudeau A; Cogné M; Dubus P; Denizot Y
    Am J Pathol; 2012 Apr; 180(4):1688-701. PubMed ID: 22326754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and characterization of a novel CCND1/MRCK gene fusion in mantle cell lymphoma.
    Masamha CP; Albrecht TR; Wagner EJ
    J Hematol Oncol; 2016 Mar; 9():30. PubMed ID: 27025456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perinucleolar relocalization and nucleolin as crucial events in the transcriptional activation of key genes in mantle cell lymphoma.
    Allinne J; Pichugin A; Iarovaia O; Klibi M; Barat A; Zlotek-Zlotkiewicz E; Markozashvili D; Petrova N; Camara-Clayette V; Ioudinkova E; Wiels J; Razin SV; Ribrag V; Lipinski M; Vassetzky YS
    Blood; 2014 Mar; 123(13):2044-53. PubMed ID: 24452204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Richter's and prolymphocytic transformation of chronic lymphocytic leukemia are associated with high mRNA expression of activation-induced cytidine deaminase and aberrant somatic hypermutation.
    Reiniger L; Bödör C; Bognár A; Balogh Z; Csomor J; Szepesi A; Kopper L; Matolcsy A
    Leukemia; 2006 Jun; 20(6):1089-95. PubMed ID: 16541139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pathologic diagnosis of mantle cell lymphoma.
    Li S; Xu J; You MJ
    Histol Histopathol; 2021 Oct; 36(10):1037-1051. PubMed ID: 34114641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subclonal evolution of a classical Hodgkin lymphoma from a germinal center B-cell-derived mantle cell lymphoma.
    Schneider S; Crescenzi B; Schneider M; Ascani S; Hartmann S; Hansmann ML; Falini B; Mecucci C; Tiacci E; Küppers R
    Int J Cancer; 2014 Feb; 134(4):832-43. PubMed ID: 23929122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of t(12;14)(p13;q32) in a patient with IGH-CCND1 negative mantle cell lymphoma resembling ultra-high risk chronic lymphocytic leukemia.
    Miao Y; Wang R; Fan L; Qiu H; Wu Y; Chen Y; Xu W; Li J
    Int J Clin Exp Pathol; 2015; 8(6):7494-8. PubMed ID: 26261659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary large B-cell lymphoma of the central nervous system with cyclin D1 expression and t(11;14) (IGH-CCND1): Diffuse large B-cell lymphoma with CCND1 rearrangement or mantle cell lymphoma?
    Parrott AM; Haggiagi AM; Murty VV; Bhagat G; Alobeid B
    Hematol Oncol; 2020 Dec; 38(5):817-822. PubMed ID: 32639587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relevance of cyclin D1b expression and CCND1 polymorphism in the pathogenesis of multiple myeloma and mantle cell lymphoma.
    Krieger S; Gauduchon J; Roussel M; Troussard X; Sola B
    BMC Cancer; 2006 Oct; 6():238. PubMed ID: 17022831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation-induced cytidine deaminase causes recurrent splicing mutations in diffuse large B-cell lymphoma.
    Benitez-Cantos MS; Cano C; Cuadros M; Medina PP
    Mol Cancer; 2024 Feb; 23(1):42. PubMed ID: 38402205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexistence of BCL1/CCND1 and CMYC aberrations in blastoid mantle cell lymphoma: a rare finding associated with very poor outcome.
    Michaux L; Wlodarska I; Theate I; Stul M; Scheiff JM; Deneys V; Ferrant A; Hagemeijer A
    Ann Hematol; 2004 Sep; 83(9):578-83. PubMed ID: 15138714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. t(11;14)-positive mantle cell lymphomas lacking cyclin D1 (CCND1) immunostaining because of a CCND1 mutation or exclusive expression of the CCND1b isoform.
    Iaccarino I; Afify L; Aukema SM; Reddemann K; Schütt P; Flür M; Klapper W
    Haematologica; 2018 Sep; 103(9):e432-e435. PubMed ID: 29773591
    [No Abstract]   [Full Text] [Related]  

  • 20. Truncation in CCND1 mRNA alters miR-16-1 regulation in mantle cell lymphoma.
    Chen RW; Bemis LT; Amato CM; Myint H; Tran H; Birks DK; Eckhardt SG; Robinson WA
    Blood; 2008 Aug; 112(3):822-9. PubMed ID: 18483394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.